Your browser doesn't support javascript.
loading
Transcatheter edge-to-edge repair in papillary muscle injury complicating acute myocardial infarction.
Haberman, Dan; Estévez-Loureiro, Rodrigo; Czarnecki, Andrew; Denti, Paolo; Villablanca, Pedro; Spargias, Konstantinos; Sudarsky, Doron; Perl, Leor; Fefer, Paul; Manevich, Lisa; Masiero, Giulia; Nombela-Franco, Luis; Poles, Lion; Caneiro-Queija, Berenice; Bowers, Nicolas; Schiavi, Davide; Tarantini, Giuseppe; Melillo, Francesco; Chrissoheris, Michael; Dvir, Danny; Maisano, Francesco; Taramasso, Maurizio; Shuvy, Mony.
Affiliation
  • Haberman D; Heart Center, Kaplan Medical Center, Rehovot, Affiliated to the Hebrew University, Jerusalem, Israel.
  • Estévez-Loureiro R; Division of Interventional Cardiology, Hospital Álvaro Cunqueiro, Vigo, Spain.
  • Czarnecki A; Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Denti P; Department of Cardiovascular Surgery, San Raffaele University Hospital, Milan, Italy.
  • Villablanca P; Department of Interventional Cardiology, The Center for Structural Heart Disease, Henry Ford Hospital, Detroit, MI, USA.
  • Spargias K; Department of Transcatheter Heart Valves, HYGEIA Hospital, Athens, Greece.
  • Sudarsky D; Cardiovascular Institute, Baruch Padeh Medical Center, Poriya, Israel.
  • Perl L; Department of Cardiology, Faculty of Medicine, Rabin Medical Center and the "Sackler", Tel Aviv University, Tel Aviv, Israel.
  • Fefer P; Leviev Heart Center, Sheba Medical Center & Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Manevich L; Department of Cardiology, E. Wolfson Medical Center, Holon and Tel Aviv University, Tel Aviv, Israel.
  • Masiero G; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Nombela-Franco L; Hospital Clínico San Carlos, Instituto de Investigacion Sanitaria San Carlos, IdISSC, Madrid, Spain.
  • Poles L; Heart Center, Kaplan Medical Center, Rehovot, Affiliated to the Hebrew University, Jerusalem, Israel.
  • Caneiro-Queija B; Division of Interventional Cardiology, Hospital Álvaro Cunqueiro, Vigo, Spain.
  • Bowers N; Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Schiavi D; Department of Cardiovascular Surgery, San Raffaele University Hospital, Milan, Italy.
  • Tarantini G; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Melillo F; Department of Cardiovascular Surgery, San Raffaele University Hospital, Milan, Italy.
  • Chrissoheris M; Department of Transcatheter Heart Valves, HYGEIA Hospital, Athens, Greece.
  • Dvir D; Jesselson Integrated Heart Centre, Shaare Zedek Medical Center / The Eisenberg R&D Authority, Hebrew University, Jerusalem, Israel.
  • Maisano F; Department of Cardiovascular Surgery, San Raffaele University Hospital, Milan, Italy.
  • Taramasso M; HerzZentrum Hirslanden Zürich, Zurich, Switzerland.
  • Shuvy M; Jesselson Integrated Heart Centre, Shaare Zedek Medical Center / The Eisenberg R&D Authority, Hebrew University, Jerusalem, Israel.
ESC Heart Fail ; 11(2): 1218-1227, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38303542
ABSTRACT

AIMS:

Acute mitral regurgitation (MR) in the setting of myocardial infarction (MI) may be the result of papillary muscle rupture (PMR). This condition is associated with high morbidity and mortality. We aim to evaluate the feasibility of transcatheter edge-to-edge mitral valve repair (TEER) in this acute setting. METHODS AND

RESULTS:

We analysed data from the International Registry of MitraClip in Acute Mitral Regurgitation following acute Myocardial Infarction (IREMMI) of 30 centres in Europe, North America, and the middle east. We included patients with post-MI PMR treated with TEER as a salvage procedure, and we evaluated immediate and 30-day outcomes. Twenty-three patients were included in this analysis (9 patients suffered complete papillary muscle rupture, 9 partial and 5 chordal rupture). The patients' mean age was 68 ± 14 years. Patients were at high surgical risk with median EuroSCORE II 27% (IQR 16, 28) and 20 out of 23 (87% were in cardiogenic shock). All patients were treated with vasopressors, and 17 out of 23 patients required mechanical support. TEER procedure was performed on the median 6 days after the index MI date IQR (3, 11). Procedural success was achieved in 87% of patients. The grade of MR was significantly decreased after the procedure. MR reduction to 0 or 1 + was achieved in 13 patients (57%), to 2 + in 7 patients (30%), P < 0.01. V-Wave was reduced from 49 ± 8 mmHg to 26 ± 10 mmHg post-procedure, P < 0.01. Sixteen out of 23 patients (70%) were discharged from hospital and 5 of them required reintervention with surgical mitral valve replacement. No additional death at 1 year was documented.

CONCLUSIONS:

TEER is a feasible therapy in critically ill patients with PMR due to a recent MI. TEER may have a role as salvage treatment or bridge to surgery in this population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitral Valve Insufficiency / Myocardial Infarction Limits: Aged / Aged80 / Humans / Middle aged Language: En Journal: ESC Heart Fail Year: 2024 Document type: Article Affiliation country: Israel

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitral Valve Insufficiency / Myocardial Infarction Limits: Aged / Aged80 / Humans / Middle aged Language: En Journal: ESC Heart Fail Year: 2024 Document type: Article Affiliation country: Israel
...